VBIO

Conviction 0HealthcareScan · Fri, Oct 2, 2026

Valion Bio, Inc. (VBIO) closed at $2.59 (+3.19%) on Oct 2, 2026. Price is below its 50-day. RSI(14) 39, -92.3% from its 52-week high, -91.5% year to date. Sector: Healthcare · Pharmaceutical Preparations.

VBIO$2.59+3.19%

ResistanceSupportVol 14

Vol MA14 4.89M

Jul 7Jul 23Aug 11Aug 27Sep 16Oct 2

Valion Bio, Inc.Pharmaceutical Preparationswww.tivichealth.com ↗

Price2.59

Change+3.19%

Gap-0.80%

Rel volume0.12×

Avg volume3.47M

Avg $ vol10.03M

SMA 202.51

SMA 504.78

SMA 200—

Price vs 50-46.32%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 4.45

RSI (14)39

MACD hist0.24

MACD cross—

Stoch %K / %D22 / 25

ADX (14)49

+DI / −DI39 / 12

RSI divergenceBullish

MACD divergenceBullish

ATR %35.14%

ADR %18.29%

52w high33.30

52w low2.08

From 52w high-92.30%

Above 52w low+23.32%

New 52w highNo

SqueezeOn · 9d

Bollinger width56.07%

%B0.54

Donchian pos22.01%

Donchian high4.39

Donchian low2.05

AVWAP (52w high)4.25

vs AVWAP high-39.71%

AVWAP (52w low)3.19

vs AVWAP low-19.58%

OBV trendDown

Chaikin MF (20)-0.47

Today vs 20d0.12×

Avg vol (14d)4.91M

Avg vol (20d)3.47M

Avg $ vol (20d)10.03M

Market cap56.92M

RS Rating—

RS 3m (vs SPY)-85.63%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank19.4

1 week-15.35%

1 month-17.79%

3 months-83.19%

6 months—

1 year—

YTD-91.53%

P/E-6.41

P/B13.40

P/S—

P/FCF-8.09

EPS-19.68

Div yield—

ROE-209.09%

ROA-27.34%

Debt/Eq—

Current1.11

EV/EBITDA-6.94

Gross margin—

Net margin—

Rev growth—

EPS growth-56.99%

Price target—

Target upside—

Analyst rating—

Institutional1.79%

Ent. value54.81M

Revenue146K

Net income-7.1M

Gross profit-145K

Free cash flow-7.04M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out3.2M

Employees52

ListedThu, Nov 11, 2021

Free float3.09M

Float %98.5%

Short interest340.19K

Days to cover0.4d

Short volume67.7%

Squeeze score43 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank19.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance22.32

Support2.23

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VBIO

All disclosures →

No recent disclosed trades by Congress in VBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VBIO

Insider	Side	Shares	Value	Traded	Filed
Wolf Lisa G Chief Financial Officer · Restricted Stock Units · 2026-06-18	Exercise	92	—	2026-06-18	2026-06-18
Wolf Lisa G Chief Financial Officer · Common Stock · 2026-06-18	Exercise	92	—	2026-06-18	2026-06-18
Handley Michael K Chief Executive Officer · Common Stock · 2026-05-18	Exercise	2.21K	—	2026-05-18	2026-05-20
Handley Michael K Chief Executive Officer · Restricted Stock Units · 2026-05-18	Exercise	2.21K	$0	2026-05-18	2026-05-20
Lackey Melinda General Counsel & SVP of Legal · Employee Stock Option (Right to Purchase) · 2026-05-01	Grant	45K	$0	2026-05-01	2026-05-04

SEC filings

EDGAR filings in VBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.